i3 Verticals (IIIV) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
23 Dec, 2025Executive summary
Q1 FY2025 revenue from continuing operations grew 12.1% year-over-year to $61.7 million, driven by strong Public Sector and Healthcare performance and recurring and software license revenues.
Adjusted EBITDA rose 17% to $16.4 million, with margin improving to 26.5%, and SaaS revenue grew 16% year-over-year.
Net income from continuing operations was $3.3 million, reversing a prior year loss of $4.2 million, and diluted EPS from continuing operations was $0.09, up from $(0.12).
78% of revenues were recurring, with ARR reaching $193.3 million, up 7.6% year-over-year.
Sale of Merchant Services Business completed in September 2024, with results now focused on software and related services.
Financial highlights
Recurring revenue for Q1 FY2025 was $48.3 million, up from $44.9 million in Q1 FY2024.
Pro forma adjusted diluted EPS from continuing operations was $0.31, up from $0.12 in the prior year.
Annualized Recurring Revenue (ARR) reached $193.3 million, up 7.6% year-over-year.
Adjusted EBITDA margin improved to 26.5% from 25.4% year-over-year.
Interest expense dropped 89.8% to $0.7 million, reflecting lower average debt balances.
Outlook and guidance
FY2025 revenue guidance: $243–$263 million; Adjusted EBITDA: $63–$71.5 million.
Pro forma adjusted diluted EPS guidance: $1.05–$1.25, assuming a 25% tax rate.
High single-digit organic revenue growth and 50–100 basis points of annual EBITDA margin improvement expected.
Guidance excludes impacts from acquisitions, dispositions, and transaction-related costs.
Latest events from i3 Verticals
- Justice and education drive SaaS growth as high-margin acquisitions boost recurring revenue.IIIV
Morgan Stanley Technology, Media & Telecom Conference 20263 Mar 2026 - JusticeTech leads growth as AI and M&A drive deeper public sector software integration.IIIV
47th Annual Raymond James Institutional Investor Conference2 Mar 2026 - Revenue and recurring growth drive raised 2026 outlook, supported by a strategic acquisition.IIIV
Q1 20266 Feb 2026 - Q3 revenue down 2%, ARR up 4%, and a $440M business sale signals strategic transformation.IIIV
Q3 20241 Feb 2026 - Annual meeting to vote on directors, auditor ratification, and executive compensation.IIIV
Proxy Filing15 Jan 2026 - Annual meeting covers director elections, auditor ratification, and executive pay approval.IIIV
Proxy Filing15 Jan 2026 - Q4 revenue up 4% to $60.9M, ARR up 7.5%, and strong 2025 growth outlook.IIIV
Q4 202413 Jan 2026 - Annual meeting to elect directors, ratify auditor, and approve executive pay; no 2024 bonuses.IIIV
Proxy Filing1 Dec 2025 - Key votes include director elections, auditor ratification, and executive pay approval.IIIV
Proxy Filing1 Dec 2025